Quesnay's Female Founders in Tech Competition Announce Winners
Jennifer Byrne, President and Co-founder of Quesnay, and Tanya Van Court, Founder and CEO of Goalsetter, discuss women in fintech, how Goalsetter stole the top prize, and how women can prosper in the space going forward.
Tanya came up with the idea of "Goalsetter" after her daughter expressed a desire to save money. Byrne digs into the nature of the competition, the inspiration behind it, and why women face a more difficult time acquiring VC funding for their ideas. Over 100 women applied, and judges narrowed down the applicants to 7 who met with judges to pitch their ideas.
Walmart, which became the nation’s largest retailer by making low prices a priority, has found itself in a place it’s rarely been: Warning customers that prices will rise for goods ranging from bananas to car seats.
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
American businesses that rely on Chinese goods are reacting with muted relief after the U.S. and China agreed to pause their exorbitant tariffs on each other’s products for 90 days. Many companies delayed or canceled orders after President Donald Trump last month put a 145% tariff on items made in China. Importers still face relatively high tariffs, however, as well as uncertainty over what will happen in the coming weeks and months. The temporary truce was announced as retailers and their suppliers are looking to finalize their plans and orders for the holiday shopping season. They’re concerned a mad scramble to get goods onto ships will lead to bottlenecks and increased shipping costs.
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.